JnJ 실시간 차트

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

JnJ news

Tommy Yap 2025 Jul 12, 21:00

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

Forex Indices
Tommy Yap 2025 Apr 12, 16:00

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Forex Indices
ECB set to cut rates for the third time this year
Neil Wilson 2024 Oct 10, 16:00

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Forex Indices
US earnings season kicks off, ECB expected to hold rates steady
Neil Wilson 2024 Jul 11, 21:00

Week ahead: US earnings season kicks off, ECB hold expected

Forex Indices
Oil steady, gold bearish trend
Neil Wilson 2024 Jan 22, 08:15

Europe Tries to Ride on US Coat-tails

Stocks Forex Commodities Indices

최신 뉴스

더 보기
Sophia Claire 2025 Sep 08, 15:20

Trump's Conflicts of Interest: How His Empire Benefits from the Presidency?

Sophia Claire 2025 Sep 08, 15:20

Betsent's Tightrope Walk: Navigating Fed Chair Selection Under Trump's Watch

Ava Grace 2025 Sep 08, 14:20

US Job Growth Revision: Potential Impact on Fed Policy

Liam James 2025 Sep 08, 10:20

Trump Family's Crypto Ventures: Billion-Dollar Wealth in Weeks

Liam James 2025 Sep 08, 10:20

El Salvador Diversifies Reserves with Gold Purchase After Bitcoin Plans Paused Amid IMF Pressure

Sophia Claire 2025 Sep 08, 10:20

Japan Leadership Race: Takaichi vs. Koizumi for Prime Minister

Sophia Claire 2025 Sep 08, 09:20

EU Eyes New Russia Sanctions Targeting Banks, Energy Over Ukraine War

Liam James 2025 Sep 08, 08:20

Gold Price Surges to Record High on Fed Rate Cut Expectations

정보

스프레드

1.08

스프레드(%)

0.6078 %

레버리지

1:2

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 폐장

화요일

13:31 - 19:59

월요일

13:31-19:59

수요일

13:31-19:59

목요일

13:31-19:59

금요일

13:31-19:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

429720076288

발행 주식 수

2408339968

수익 날짜 (다음)

2001-06-13

배당수익률

2025-09-09

배당락일

2025-08-26

예상 연간 배당금

5.2

예상 연간 배당수익률

0.0291

EPS

9.33

이 상품에 대해 자세히 알아보기

JnJ Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.

latest_education_articles

더 보기
Trustpilot